New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - fexofenadine hydrochloride 120mg; fexofenadine hydrochloride 120mg - film coated tablet - 120 mg - active: fexofenadine hydrochloride 120mg excipient: croscarmellose sodium hyprolose hypromellose iron oxide red iron oxide yellow macrogol 400 magnesium stearate microcrystalline cellulose opacode black s-1-8152hv povidone purified talc purified water titanium dioxide active: fexofenadine hydrochloride 120mg excipient: croscarmellose sodium hyprolose hypromellose iron oxide red iron oxide yellow macrogol 400 magnesium stearate microcrystalline cellulose opacode black s-1-27794 povidone purified talc purified water titanium dioxide

New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - fexofenadine hydrochloride 180mg; fexofenadine hydrochloride 180mg - film coated tablet - 180 mg - active: fexofenadine hydrochloride 180mg excipient: croscarmellose sodium hyprolose hypromellose iron oxide red iron oxide yellow macrogol 400 magnesium stearate microcrystalline cellulose opacode black s-1-8152hv povidone purified talc purified water titanium dioxide active: fexofenadine hydrochloride 180mg excipient: croscarmellose sodium hyprolose hypromellose iron oxide red iron oxide yellow macrogol 400 magnesium stearate microcrystalline cellulose opacode black s-1-27794 povidone purified talc purified water titanium dioxide

New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - azathioprine 50mg;   - film coated tablet - 50 mg - active: azathioprine 50mg   excipient: croscarmellose sodium maize starch mannitol microcrystalline cellulose opadry clear oy-7240 povidone sodium stearyl fumarate - azamun is used as an immunosuppressant anti-metabolite either alone, or more commonly in combination with other agents (usually corticosteroids) and procedures that influence the immune response. the therapeutic effect of azamun may be evident only after weeks or months and can include a steroid-sparing effect, thereby reducing the toxicity associated with high dosage and prolonged use of corticosteroids. azamun, in combination with corticosteroids and/or other immune-suppressive agents and procedures is indicated to enhance survival of organ transplants, such as renal, cardiac and hepatic transplants; and to reduce corticosteroid requirements of renal transplant recipients.

New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - flucloxacillin sodium monohydrate 1 g;   - powder for injection - 1 g - active: flucloxacillin sodium monohydrate 1 g   - latest regulatory activity

New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - flucloxacillin sodium monohydrate 250mg;   - powder for injection - 250 mg - active: flucloxacillin sodium monohydrate 250mg  

New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - flucloxacillin sodium monohydrate 500mg;   - powder for injection - 500 mg - active: flucloxacillin sodium monohydrate 500mg  

New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - rabeprazole sodium 10mg equivalent to rabeprazole 9.42 mg - enteric coated tablet - 10 mg - active: rabeprazole sodium 10mg equivalent to rabeprazole 9.42 mg excipient: dibutyl sebacate ethylcellulose heavy magnesium oxide   hyprolose hypromellose phthalate iron oxide red magnesium stearate mannitol purified talc titanium dioxide - prolox is indicated for: · treatment and prevention of relapse of gastro-oesophageal reflux disease · symptomatic treatment of gastro-oesophageal reflux disease · treatment of duodenal ulcers · treatment of gastric ulcers. patients whose gastric and duodenal ulceration is not associated with ingestion of non-steroidal anti-inflammatory drugs (nsaids) usually require treatment with antimicrobial agents in addition to antisecretory drugs whether on first presentation or on recurrence.

New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - rabeprazole sodium 20mg equivalent to rabeprazole 18.85 mg - enteric coated tablet - 20 mg - active: rabeprazole sodium 20mg equivalent to rabeprazole 18.85 mg excipient: dibutyl sebacate ethylcellulose heavy magnesium oxide   hyprolose hypromellose phthalate iron oxide yellow magnesium stearate mannitol purified talc titanium dioxide - prolox is indicated for: · treatment and prevention of relapse of gastro-oesophageal reflux disease · symptomatic treatment of gastro-oesophageal reflux disease · treatment of duodenal ulcers · treatment of gastric ulcers. patients whose gastric and duodenal ulceration is not associated with ingestion of non-steroidal anti-inflammatory drugs (nsaids) usually require treatment with antimicrobial agents in addition to antisecretory drugs whether on first presentation or on recurrence.

New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - ketoconazole 20.6 mg/ml;  ;  ;   - shampoo - 2% w/w - active: ketoconazole 20.6 mg/ml       excipient: cocamide diolamine diazolidinyl urea erythrosine hydrochloric acid herb flower fragrance polyethylene glycol distearate purified water sodium laureth sulfate sodium lauril sarcosinate - treatment of seborrhoeic dermatitis and severe dandruff of the scalp in adults.

New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - sildenafil citrate 140.48mg equivalent to 100 mg sildenafil;  ;   - tablet - 100 mg - active: sildenafil citrate 140.48mg equivalent to 100 mg sildenafil     excipient: croscarmellose sodium hypromellose indigo carmine lactose monohydrate macrogol 6000 magnesium stearate microcrystalline cellulose povidone titanium dioxide - sildenafil is indicated for the treatment of erectile dysfunction in adult males.